{"metadata": {"source": "pubchem", "title": "Phencyclidine | C17H25N | CID 6468 - PubChem", "description": "Phencyclidine | C17H25N | CID 6468 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/6468", "drug": "Phencyclidine", "cid": 6468, "char_count": 115379, "word_count": 15371, "doc_id": "doc_59", "num_chunks": 166, "chunk_id": "59::chunk_89", "document_index": 59, "latency_s": 1.1228650999983074, "prompt_toks": 30404, "completion_toks": 63, "relevance_score": 8.902264e-08}, "content": "Drug: Phencyclidine | cid: 6468\nSource: pubchem | Source description: Phencyclidine | C17H25N | CID 6468 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    then decreased to 0.9% in 2012.[US DEA; Drugs and Chemicals of Concern. Phencyclidine. Washington, DC: US Dept Just., Drug Enforc Admin, Off Diversion Control. Available from, as of Sept 14, 2017: https://www.deadiversion.usdoj.gov/index.html]\n\n\n                    Context: \n                    This section provides data on the historical and current prevalence of phencyclidine use, highlighting a significant decline in illicit use over time. The reference to the US DEA report underscores the decrease in reported cases, which is relevant for understanding trends in drug abuse and relevant for toxicity and regulatory considerations discussed in the full document.\n                "}
{"metadata": {"source": "pubchem", "title": "Methamphetamine | C10H15N | CID 10836 - PubChem", "description": "Methamphetamine | C10H15N | CID 10836 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/10836", "drug": "Methamphetamine", "cid": 10836, "char_count": 131280, "word_count": 16880, "doc_id": "doc_35", "num_chunks": 185, "chunk_id": "35::chunk_55", "document_index": 35, "latency_s": 1.5586543999961577, "prompt_toks": 33662, "completion_toks": 72, "relevance_score": 8.362903e-08}, "content": "Drug: Methamphetamine | cid: 10836\nSource: pubchem | Source description: Methamphetamine | C10H15N | CID 10836 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    and increased again as drug makers circumvented precursor restrictions (2008-2012). Seven percent of meth-related chemical incidents resulted in injuries to 162 persons, mostly members of the general public (97 persons, including 26 children) and law enforcement officials (42). Recent trends suggest a need for efforts to protect the general public, particularly children and law enforcement officials. Because individual state legislative actions can result in increased illegal meth production in neighboring states, a regional approach to prevention is recommended.\n\n\n                    Context: \n                    This excerpt summarizes recent trends in methamphetamine manufacturing and associated chemical incidents, highlighting increased circumventing of precursor restrictions between 2008-2012 and the resulting injuries, predominantly affecting the public and law enforcement. It underscores the importance of regional prevention efforts and situates within the broader discussion of illicit production, safety hazards, and regulatory challenges covered in the full document.\n                "}
{"metadata": {"source": "erowid", "title": "Erowid Amphetamines Vault : Timeline", "description": "A timeline of events in the history of Amphetamines", "language": "No language found.", "url": "https://www.erowid.org/chemicals/amphetamines/amphetamines_timeline.php", "drug": "Amphetamine", "cid": 3007, "substance": "amphetamines", "category": "CHEMICALS", "erowid_column": "History", "char_count": 11666, "word_count": 1679, "doc_id": "doc_123", "num_chunks": 16, "chunk_id": "123::chunk_13", "document_index": 123, "latency_s": 0.7037961000023643, "prompt_toks": 3258, "completion_toks": 86, "relevance_score": 7.496458e-08}, "content": "Drug: Amphetamine | cid: 3007\nSource: erowid | Source description: A timeline of events in the history of Amphetamines\nErowid name: amphetamines\nCategory: CHEMICALS\nField: History\n\n                    Text: \n                    Methamphetamine Epidemic Act of 2005\" provides for criminal penalties for non-compliance with the DEA rules and limits maximum amount any individual can purchase per month to 9 grams. Jul 2, 2007 Lisdexamfetamine dimesylate is released onto the market under the trade name Vyvanse by Shire.  Their goal is/was to have Vyvanse take Adderall XR's place as the top-selling ADHD medicine [in the U.S.]. [More Info] 2011 The United Nations Office on Drugs and Crime declares that 2011 saw the highest level of law enforcement seizures of amphetamine-type stimulants in history. Global amphetamine-type stimulant ATS seizures rise to highest level ever recorded. [...] The overall increase in ATS seizures is mainly due to surging methamphetamine seizures, which grew by 73 per cent from 51 tons in 2010 to 88 tons in 2011. 9\n\n\n                    Context: \n                    This chunk details recent legislative and international developments related to methamphetamine, including the 2005 Methamphetamine Epidemic Act's restrictions and penalties, the market release of Vyvanse in 2007, and the 2011 surge in global amphetamine seizures reported by the UNODC. It is relevant within the document's broader discussion of the history, regulation, and law enforcement response to amphetamines and methamphetamine worldwide.\n                "}
